TMPRSS-2 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human TMPRSS2 (O15393) expressed in HEK293. Suited to serine protease activity assays, inhibitor IC50 work, substrate cleavage studies, and antibody validation alongside RP-TMPRSS2.
Expression system
HEK293
Cat. #
REC-TMPRSS2

In stock

SKU
REC-TMPRSS2
$498.00

Target Overview

REC-TMPRSS2 is a recombinant form of human transmembrane protease serine 2 (TMPRSS2, UniProt O15393, EC 3.4.21.122) produced in HEK293 cells. Mammalian expression preserves the post-translational modifications and disulfide architecture required for proper folding of the trypsin-like serine protease domain, which in the native enzyme follows autocatalytic cleavage between the non-catalytic and catalytic chains. The full-length precursor is 492 amino acids; the catalytic chain carrying the His-Asp-Ser triad is liberated by zymogen processing at an arginine residue, consistent with TMPRSS2's preference for cleavage after basic residues. Researchers use this recombinant as the enzyme component in fluorogenic peptide cleavage assays (for example Boc-Gln-Ala-Arg-AMC and related Arg-P1 substrates), as the target enzyme in small-molecule inhibitor screens and IC50 determinations (camostat, nafamostat, and aprotinin-class inhibitors are common comparators in the published literature), and as a substrate-presenting enzyme for cleavage studies on candidate substrates including the SARS-CoV-2 spike S1/S2 and S2′ sites, pro-HGF, PAR2/F2RL1, and matriptase/ST14. The protein is also useful as a positive control and immunogen reference for Western blot and IHC validation. Researchers running orthogonal validation can pair REC-TMPRSS2 with the matched Triple Point antibody RP-TMPRSS2 to confirm band identity, demonstrate signal loss in knockout or knockdown lysates, and titrate antibody concentration against a known input of recombinant protein. Supplied for research use only; not for diagnostic or therapeutic application.

Background

TMPRSS2 is a type II transmembrane serine protease of the hepsin/TMPRSS subfamily, anchored at the plasma membrane with an extracellular protease domain that cleaves substrates C-terminal to arginine. The gene is androgen-regulated and abundantly expressed in prostate epithelium, where TMPRSS2 participates in proteolytic cascades relevant to prostate physiology and has been characterised as an activator of pro-hepatocyte growth factor (pro-HGF), protease-activated receptor 2 (F2RL1/PAR2), and matriptase (ST14). Recurrent TMPRSS2–ERG gene fusions in prostate adenocarcinoma have made the enzyme a well-studied research target in oncology, and recombinant TMPRSS2 is routinely used in substrate identification and inhibitor profiling experiments aimed at this biology. Beyond the prostate, TMPRSS2 has become a focus of respiratory virology. The enzyme primes the spike glycoproteins of several coronaviruses — including SARS-CoV, MERS-CoV, and SARS-CoV-2 — and the haemagglutinins of influenza A subtypes, enabling membrane fusion at the cell surface or in early endosomes. Comparative reviews of airway mucosal injury describe TMPRSS2-dependent entry as a shared determinant of pathogen tropism across SARS-CoV-2, influenza A, and other respiratory agents (PMID 42211665), and recent SARS-CoV-2 intra-host recombination work has examined how spike epistasis interacts with TMPRSS2-mediated priming under temperature-shifted conditions (PMID 42213788). Expression studies in human lung tissue continue to map TMPRSS2 protein abundance across age groups alongside ACE2 and SIRT1, providing context for differential susceptibility to coronavirus infection. Preclinical antiviral programmes use recombinant TMPRSS2 to screen camostat- and nafamostat-class inhibitors, peptidomimetics, and repurposed serine protease blockers, and recombinant enzyme is also applied in mechanistic studies of bovine and other animal coronavirus entry pathways. Researchers selecting reagents for these workflows typically require a folded, catalytically competent recombinant produced in a mammalian system; REC-TMPRSS2 is supplied in that format for activity, binding, and antibody validation work.

Applications

  • Fluorogenic peptide cleavage assays using Arg-P1 substrates (e.g. Boc-Gln-Ala-Arg-AMC) to measure serine protease activity
  • IC50 determination for camostat-, nafamostat-, and aprotinin-class TMPRSS2 inhibitors
  • SARS-CoV-2 spike S1/S2 and S2′ in vitro cleavage and priming studies
  • Substrate identification for pro-HGF, PAR2/F2RL1, and matriptase/ST14 by mass spectrometry
  • Positive control and loading standard for Western blot validation of anti-TMPRSS2 antibodies
  • Antibody titration and specificity testing paired with matched antibody RP-TMPRSS2
  • Surface plasmon resonance and biolayer interferometry binding studies with inhibitors or antibodies
  • Enzyme component in pseudovirus entry and cell-surface priming assays

References

  1. Chen C et al. Bovine coronavirus enters PBIECs via membrane fusion and clathrin-, caveolin-mediated endocytosis, macropinocytosis. Virulence. 2026. PMID: 42334091. doi:10.1080/21505594.2026.2691344
  2. Lamounier ACA et al. Expression of angiotensin-converting enzyme 2, transmembrane serine protease 2, and sirtuin 1 proteins in lungs of different age groups. J Bras Pneumol. 2026. PMID: 42307333. doi:10.36416/1806-3756/e20250127
  3. Altaf M et al. SARS-CoV-2 intra-host recombination promotes epistatic spike interactions and temperature-dependent adaptation. Cell Rep. 2026. PMID: 42213788. doi:10.1016/j.celrep.2026.117460
  4. Jia Y. Comparative progress on the mechanisms of airway mucosal injury induced by different pathogens: SARS-CoV-2, influenza A virus, and Mycoplasma pneumoniae. Front Cell Infect Microbiol. 2026. PMID: 42211665. doi:10.3389/fcimb.2026.1777403
  5. Brüssow H. Extending the Targets for Coronavirus Antivirals Beyond That of Approved Drugs: Insights From Preclinical Research. Microb Biotechnol. 2026. PMID: 42171504. doi:10.1111/1751-7915.70376

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type II transmembrane serine protease; cell surface

Frequently Asked Questions

What molecular weight band does recombinant TMPRSS-2 run at on SDS-PAGE or Western blot?

The full-length TMPRSS-2 precursor (492 aa, UniProt O15393) has a predicted molecular weight of ~54 kDa, but glycosylation in HEK293 cells typically shifts the apparent MW to ~60–70 kDa under reducing SDS-PAGE conditions. After autocatalytic zymogen processing, the catalytic chain runs at approximately 30–35 kDa. When running REC-TMPRSS2 as a Western blot standard, expect a predominant band in the 60–70 kDa range for the unprocessed form, with a secondary band at ~30–35 kDa reflecting processed enzyme. Purity is >95% by SDS-PAGE.

Is REC-TMPRSS2 the full-length precursor or the processed catalytic chain, and does that affect activity?

REC-TMPRSS2 is produced as the full-length 492 aa precursor in HEK293 cells. Consistent with native TMPRSS-2 biology, autocatalytic cleavage at an Arg residue liberates the trypsin-like serine protease catalytic chain carrying the canonical His-Asp-Ser triad. Because the protein is expressed in a mammalian system, zymogen processing occurs during production, so the preparation contains a mixture of precursor and active catalytic chain. For activity-dependent experiments — peptide cleavage assays, inhibitor screens — the active cleaved form is the relevant species and is functional as supplied.

What fluorogenic peptide substrate should I use for a TMPRSS-2 activity assay with this recombinant?

Boc-Gln-Ala-Arg-AMC is the most widely cited fluorogenic substrate for TMPRSS-2 in the published literature, reflecting the enzyme's preference for cleavage after basic (Arg/Lys) P1 residues. Other Arg-P1 AMC substrates (e.g., Boc-Phe-Ser-Arg-AMC) are also compatible. For a standard activity assay, use 100–500 µM substrate in 50 mM Tris-HCl pH 8.0, 150 mM NaCl at 37°C, monitoring AMC release at Ex/Em 355/460 nm. Initial velocity should be linear over at least 30 minutes before substrate depletion becomes significant.

What buffer and pH conditions are optimal for TMPRSS-2 serine protease activity assays?

TMPRSS-2 is a trypsin-like serine protease with maximum activity in the pH 7.5–8.5 range. The storage buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol) is compatible with direct dilution into assay buffer. For activity assays, we recommend 50 mM Tris-HCl pH 8.0, 150 mM NaCl, without added calcium (TMPRSS-2 is not a metalloproteinase). Keep glycerol ≤2% in the final assay volume to avoid viscosity artifacts. Pre-warm enzyme and substrate to 37°C separately before mixing to obtain reproducible initial-rate measurements.

What starting enzyme concentration and inhibitor controls should I use for a TMPRSS-2 IC50 screen?

For IC50 determinations, 1–5 nM REC-TMPRSS2 is a reasonable starting point with 100–200 µM Boc-Gln-Ala-Arg-AMC substrate (below or at Km). Published IC50 values for common comparators — camostat mesylate (~6 nM), nafamostat (~0.3 nM), and aprotinin (~100 nM) — provide useful bracket controls to validate assay window and Z-factor. Pre-incubate enzyme with inhibitor for 15–30 minutes at room temperature before adding substrate. At these enzyme concentrations, Morrison tight-binding kinetics may apply for nanomolar inhibitors; adjust analysis accordingly.

Can I use REC-TMPRSS2 as a positive control for Western blot with the matched anti-TMPRSS-2 antibody RP-TMPRSS2?

Yes, REC-TMPRSS2 is the validated positive control for the matched rabbit polyclonal antibody RP-TMPRSS2 (/anti-tmprss-2-rabbit-polyclonal-antibody). The two are produced in the same laboratory and verified together. For a clean positive-control lane, load 50–100 ng of REC-TMPRSS2 alongside your cell lysate lanes. Expect the primary band at ~60–70 kDa (glycosylated precursor) and a secondary band at ~30–35 kDa. Because glycosylation patterns in the recombinant and endogenous protein are both derived from mammalian expression, band migration in cell lysates should closely match the recombinant standard.

How much REC-TMPRSS2 protein should I load to validate antibody RP-TMPRSS2 by Western blot?

For antibody validation purposes, a two-point loading series of 25 ng and 100 ng per lane is sufficient to demonstrate dose-dependent signal with RP-TMPRSS2 and to define the linear detection range. Run alongside a TMPRSS-2-positive cell lysate (e.g., Calu-3 or VCaP whole-cell lysate at 20–40 µg total protein). The recombinant lane confirms antibody specificity at the correct MW; the cell lysate lane confirms detection of endogenous protein. Purity of REC-TMPRSS2 is >95% by SDS-PAGE, so background bands in the recombinant lane are minimal.

How should I store and handle REC-TMPRSS2 to maintain serine protease activity over time?

REC-TMPRSS2 is supplied in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol in single-use aliquots and should be stored at -20°C. Avoid repeated freeze-thaw cycles; each additional cycle measurably reduces serine protease activity. Upon first thaw, briefly centrifuge (1,000 × g, 30 sec) and keep on ice during use. For dilutions below 10 µg/mL, add carrier protein (0.1% BSA, protease-free) to reduce adsorptive loss on tube surfaces. Aliquots are stable for ≥12 months at -20°C from the date of receipt when handled correctly.

Validation imagery coming soon

Western blot validation figures for REC-TMPRSS2 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →